(322e) Microfluidic Assembled Lipopolyplex for Antisense Oligonucleotide Delivery

For therapeutics applications, small and uniformly sized nanoparticles, polymer-based (polyplex) and lipid-based (lipopolyplex), are important for successful and efficient in vitro and in vivo gene/drug delivery. Nanoparticles, e.g. liposomes, have been studied extensively as nanocarriers because of their biocompatibility and ability to incorporate drug molecules. Conventional bulk mixing (BM) method of producing liposomes requires mixing of multiple reagents and postprocessing steps such as sonication or membrane extrusion to produce small and uniformly sized nanoparticles. Therefore, in this study, microfluidic devices and novel micromixers were developed for assembling lipopolyplex nanoparticles. The size, surface charge, morphology, and gene/drug encapsulation of the nanoparticles were characterized using dynamic light scattering, zeta potential measurement, atomic force microscopy, cryo-TEM, and gel electrophoresis. Nanoparticles encapsulating antisense oligonucleotides synthesized were evaluated for downregulation of Bcl-2, an antiapoptotic protein commonly overexpressed in many cancer cells.